SIGNIFICANT SHAREHOLDING

RNS Number : 1026Z
Oxford Biomedica PLC
12 March 2012
 

 

OXFORD BIOMEDICA PLC

SIGNIFICANT SHAREHOLDING

 

Oxford, UK - 12 March 2012: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, has been informed that on 31 January 2012, Cubana Investments Limited ("Cubana") was acquired by Vulpes Life Sciences Fund ("Vulpes"). As a consequence, on 9 March 2012 Cubana's interest in the ordinary shares of the Company were transferred to Vulpes.

 

The transfer to Vulpes has not resulted in a change in beneficial ownership of Cubana's interest in the Company as Vulpes is the new investment vehicle for the underlying owners of Cubana.

 

Following this transfer, Vulpes has an interest in 131,950,000 ordinary shares of 1 pence each representing 13.96 per cent of the issues ordinary share capital in Oxford BioMedica.

 

 

For further information, please contact:


Oxford BioMedica plc:

John Dawson, Chief Executive Officer

Tim Watts, Chief Financial Officer

Lara Mott, Head of Corporate Communications

 

 

Tel: +44 (0)1865 783 000

Singer Capital Markets Limited:

Shaun Dobson/Claes Spång

 

Tel: +44 (0)20 3205 7500

Media/Financial Enquiries:

Mary Clark/Claire Dickinson

M:Communications

 

Tel: +44 (0)20 7920 2360

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

MSCLLFERVAIAIIF